Abstract
Botulinum toxin (BoNT) has been approved for aesthetic use since 2002. Since then, clinical studies and expert use have informed our understanding of how BoNT exerts its clinical effect and the practical use of this product across a number of aesthetic applications. This review discusses the clinical properties and characteristics of abobotulinumtoxinA, which patients are suitable for its use, and how it can be utilized to treat facial rhytides.
© 2017 The American Society for Aesthetic Plastic Surgery, Inc.
MeSH terms
-
Acetylcholine Release Inhibitors / administration & dosage
-
Acetylcholine Release Inhibitors / pharmacology*
-
Botulinum Toxins, Type A / administration & dosage
-
Botulinum Toxins, Type A / pharmacology*
-
Cosmetic Techniques* / trends
-
Face / anatomy & histology*
-
Facial Muscles / drug effects
-
Humans
-
Injections, Intramuscular / instrumentation
-
Injections, Intramuscular / methods
-
Injections, Intramuscular / standards
-
Patient Selection*
-
Practice Guidelines as Topic
-
Skin Aging / drug effects*
Substances
-
Acetylcholine Release Inhibitors
-
Botulinum Toxins, Type A
-
abobotulinumtoxinA